Spatial Transcriptomics: Illuminating the Secrets of Tissue Architecture

The spatial genomics and spatial transcriptomics market is estimated to be worth $4.7 billion in 2022 and is expected to grow at compounded annual growth rate (CAGR) of 11.9% during the forecast period.

Read More: https://www.rootsanalysis.com/....reports/spatial-geno

Since the discovery of the first human genetic map in 1987, the field of omics-based analysis has evolved significantly.

Mapping the Blueprint of Life: Spatial Genomics UnraveledMapping the Blueprint of Life: Spatial Genomics Unraveled

The traditional molecular profiling analytical techniques, such as microarrays quantitative polymerase chain reaction (qPCR), flow cytometry, mass spectrometry, immunohistochemistry and enzyme linked immunosorbent (ELISA) assay, though widely adopted, are known to dissociate the tissue samples, thereby causing loss of critical spatial multi-omics information across the genome, transcriptome, and proteome.